nbia-logo1

English French German Italian Spanish
Text Size

Clinical Trials

A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

The European Union is funding a deferiprone clinical trial in the U.S. and four sites in Europe through a Seventh Framework Programme grant called Treat Iron-Related Childhood-Onset Neurodegeneration or TIRCON.

Read more...

Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Researchers at the Oregon Health & Science University have begun a new brain imaging study to explore brain blood flow, called perfusion, in pantothenate kinase-associated neurodegeneration, known as PKAN, the most common form of NBIA.

Read more...